PRO27 Pharmacoeconomic Prospects for the Use of Ravulizumab in the Treatment of Paroxysmal Nocturnal Hemoglobinuria

Autor:	I. Velum, M. Proskurin, A. S. Kolbin, Y. Balykina
Rok vydání:	2020
Předmět:	medicine.medical_specialty business.industry Health Policy Public Health Environmental and Occupational Health Paroxysmal nocturnal hemoglobinuria medicine medicine.disease business Dermatology
Zdroj:	Value in Health. 23:S694
ISSN:	1098-3015
DOI:	10.1016/j.jval.2020.08.1763
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::be17e848d857052d36e34b698dcb140d https://doi.org/10.1016/j.jval.2020.08.1763 Zobrazit plný text záznamu Full Text from ScienceDirect